Search for a command to run...
Jake Becraft describes how Strand Therapeutics is developing programmable mRNA technology to create targeted cancer treatments that activate the immune system to selectively attack tumor cells, potentially transforming cancer from a fatal disease to a manageable condition.
Two venture capitalists explore the brutal economics of biotech, revealing why the industry is struggling despite scientific advances, and how new modalities, AI, and a focus on invention could revive innovation in drug development.
In this episode, Sajith Wickramasekara, CEO of Benchling, discusses how AI can accelerate drug discovery, reduce development costs, and transform the biotech industry by making scientific research more efficient and data-driven.
Senator Rand Paul discusses the urgent need to address America's growing national debt, criticizing both Republicans and Democrats for excessive spending and warning about potential economic calamities. He also shares insights on topics ranging from trade and AI to gain-of-function research and the potential for conflict with China, emphasizing the importance of free markets, capitalism, and diplomatic nuance.